In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Message: Results due soon..
Generic_profile
Rank: [?]
Mail Room
Points: [?]
78
Rating: [?]
Votes: 1 Score: 3.0
  • Currently 3.0/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Results due soon..

posted on Nov 21, 07 02:27AM

The Company has initiated two pivotal animal studies for ARX828 and expects to receive results from these studies for analysis, by end of November.

 The Company's goal is to develop ARX828 for the treatment of Rheumatoid Arthritis and Inflammatory Bowel Disease.

hopefully we're building up to a pop on good news..

hopefully we get a PR when they get the results..

New Message

Please login to post a reply

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote